Refreshing results…
ZEB1 is a Subgroup-Specific Marker of Prognosis and Potential Drug Target in Medulloblastoma
Download from link.springer.comReceptor Tyrosine Kinases as Candidate Prognostic Biomarkers and Therapeutic Targets in Meningioma
Download from doi.orgHDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma
Download from link.springer.comMissing publications? Search for publications with a matching author name.